Lv6
2122 积分 2024-05-28 加入
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
8天前
已完结
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
8天前
已完结
Safety, pharmacokinetics and pharmacodynamics of HRS ‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial
1个月前
已完结
Translational Population‐Pharmacodynamic Modeling of a Novel Long‐Acting siRNA Therapy, Inclisiran, for the Treatment of Hypercholesterolemia
3个月前
已完结
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a)
4个月前
已完结
Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation
4个月前
已完结
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
4个月前
已完结
Stapokibart: First Approval
5个月前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis
5个月前
已完结
Efficacy and safety of REGN9933A2 and REGN7508Cat for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials
5个月前
已完结
皖公网安备34019202002308
